GlaxoSmithKline (GSK) Reports Q4 Adj-EPS of 34.4P, vs. Consensus of 33.5P
Tweet Send to a Friend
GlaxoSmithKline (NYSE: GSK) reports ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
